Verisys Appoints Scott Bagwell to Its Board of Directors

Former Experian Health President Brings Wealth of Industry Experience

Verisys

Verisys Corporation (“Verisys” or the “Company”), a leading provider of technology solutions and primary-source data on health care professionals and businesses, has added Scott Bagwell, former President of Experian Health and a health care technology industry veteran, to its board of directors. This appointment comes as Verisys continues to focus on accelerating growth, having recently raised growth capital from Spectrum Equity and Cressey & Company and expanded its product offerings.

"Scott joins us as Verisys looks to significantly expand our sales & marketing organization to capitalize on growing demand for our mission-critical data solutions,” said Verisys CEO John Benson. "I look forward to working closely with Scott to leverage his deep domain expertise across health care and reputation for delivering award winning solutions and high performing, metric driven sales and marketing teams as he did at Experian Health, Passport Health and several other world class companies.”

“Verisys is a key player in the US health care ecosystem, and is the ‘gold standard’ data provider used industry-wide for combating fraud and abuse,” said Bagwell. “I’m excited to work with John and to be a part of such a dynamic company with a highly compelling growth opportunity ahead.”

At Experian, Scott was responsible for overall leadership and management of the health business for the information services giant. Prior to taking on this role, Bagwell served as Senior Vice President of Sales Marketing and Professional Services at Experian Health and at Passport Health Communications. He has more than 25 years of industry experience leading sales and marketing teams for leading health care technology companies. Before joining Passport Health in 2010, he served as Senior Vice President for McKesson Pharmacy Systems and RelayHealth Pharmacy business units. He also held senior executive positions at Per-Se Technologies / NDCHealth Corporation, as well as Sunquest Information Systems / Misys.

About Verisys
Verisys' mission is to serve the health care sector with accurate and timely data on persons, professionals, and businesses (for contracting, privileging, enrollment, employment, reimbursement and referral validation).  Verisys solutions ensure regulatory compliance and prevent health care waste, abuse, and fraud. Verisys' products and services include provider data and content, credentialing, primary-source verification services, screening - monitoring and notification services, identity/authentication tied to credentials management and regulatory compliance products and services. Verisys' flagship product, FACIS®, is the gold standard for exclusion screening in the health care field and its SaaS credentialing platform, exclusively endorsed by the American Hospital Association, CheckMedic®, represents a breakthrough in credentialing. Verisys is an NCQA certified and URAC accredited Credentials Verification Organization.

Press Contacts
Spectrum Equity
news@spectrumequity.com

Source: Verisys

About Spectrum Equity

Spectrum Equity is a leading growth equity firm providing capital and strategic support to innovative companies in the information economy. Since 1994, the firm has partnered with proven entrepreneurs and management teams to build long-term value in market-leading internet-enabled software and data services companies. Representative investments include Ancestry, Bats Global Markets, Definitive Healthcare, GoodRx, Grubhub, Lucid, Lynda.com, SurveyMonkey and Verafin. For more information, including a complete list of portfolio investments, visit www.spectrumequity.com.

Spectrum Equity
1 International Pl. , #35th Floor
Boston, MA
02110

More Press Releases